Market Notice
The security Genetic Technologies Ltd. Registered Shares o.N. with ISIN AU000000GTG7 is currently suspended from trading. Please note that existing orders in this security have been cancelled. Orders can be placed again once trading is resumed.
Genetic Technologies Ltd. Registered Shares o.N.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
84.83%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
0.00 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
| ResMed Inc. | 32.17 Bil. | 4.73 Bil. | 27.14 | +36.48 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE | 0.029 G | 0 Units |
| PRICE DETERMINATION TIME | 10/17/2024 / 08:24:07 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.029 | 0.029 |
| PREV. DAY'S PRICE | 0.29 | (10/16) |
| CHANGE DAY BEFORE | -0.26 | -90.00 % |
| 52 WEEK HIGH / LOW | 4.7778 (12/13) | 0.0205 (08/09) |
Key Figures (in EUR)
| 2027 | 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | - | - | - | -0.06 | -0.07 |
| DIVIDENDS PER SHARE | - | - | - | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | - | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | - | - | - |
| PRICE - BOOK RATIO | - | - | - | 5.42 | 2.07 |
| PRICE - SALES RATIO | - | - | - | 1.29 | 2.92 |
| PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | 893882 |
| ISIN | AU000000GTG7 |
| SYMBOL | DU8 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Genetic Technologies |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 26.09 % | 38.10 % | 14.52 % | -66.09 % | -84.83 % | -89.88 % | -79.77 % | -58.43 % |
| HIGH | 0.29 | 0.29 | 0.29 | 0.29 | 4.78 | 4.78 | 4.78 | 0.29 |
| LOW | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Dividend
per share
Genetic Technologies does not deliver dividend information
Company profile
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Maroochydore, Australia.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.